Global cold pain therapy market forecast, analysis with overview. Top cold pain therapy market players are Hisamitsu Pharmaceutical Co. (Japan), Inc., 3M Company (U.S.) and Breg Inc. (U.S.) held the leadership position in the different products segments of the global market. Other market players include Johnson & Johnson (U.S.), Sanofi (France), and ROHTO Pharmaceutical Co., Ltd. (Japan), Medline Industries Inc. (U.S.), Ossur hf (Iceland), and DJO Finance LLC (U.S.).
- Advertising -
Download Brochure of Cold Pain Therapy Market spread across 223 Pages, Profiling 11 Companies and Supported with 59 Tables and 63 Figures is now available at www.rnrmarketresearch.com/contacts…mple?rname=725677 .
The global cold pain therapy market is estimated to grow at a CAGR of 5.0% from 2016 to 2021 to reach USD 1,087.7 million by 2021. The adoption of cold pain therapy products is rising across the globe due to the growing adoption of analgesic patches, increasing aging population, growing use of cold pain therapy among middle-aged women, and the rising preference for self-care.
- Cold pain therapy product manufacturers
- Healthcare service providers
- Distributors and suppliers
- Research laboratories and academic institutes
- Original equipment manufacturers (OEMs)
- Market research companies
Report studies cold pain therapy market based on product and application.
- Advertising -
The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
Report at www.rnrmarketresearch.com/contacts/725677 .
Global cold pain therapy market has been segmented on basis of products into OTC [pharmaceuticals (gels, ointments, and creams, sprays and foams, patches, and roll-ons) and medical devices (cold packs, cooling towels, compress, wraps, and pads)] & prescription-based devices (motorized and non-motorized devices); application (musculoskeletal disorders, sport medicine, post-operative, post-trauma, & physical therapy); & region (North America, Europe, Asia-Pacific, and the Rest of the World).
- Further breakdown of the North American market into the U.S. and Canada
- Further breakdown of the European market into Germany, U.K., France, and the Rest of Europe
- Further breakdown of the APAC market into China, Japan, India, Australia, and the Rest of APAC
- Further breakdown of the RoW market into the Middle East, Latin America, and Africa
Geographically, North America is expected to command the largest share of the global cold pain therapy market in 2016, followed by Europe. The growth in the North American market is primarily driven by various factors, including the large number of surgeries, stringent regulations on opioid prescription, and new product launches.
North America accounted for the largest share of the global market, followed by Europe. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period.
Factors such as the long-term market presence of key cold pain therapy players with established product portfolios in the region and a high preference for topical analgesics are stimulating the growth of the APAC market.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: